Skip to main content

Redesign Health

By Jessica Hagen | 11:28 am | January 07, 2026
Leaders say AI will reshape jobs without replacing the human core of care.
By Jessica Hagen | 12:39 pm | December 19, 2025
Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.
By Jessica Hagen | 11:57 am | December 12, 2025
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
By Jessica Hagen | 01:56 pm | December 04, 2025
Industry leaders say 2025 marked AI’s shift from hype to practical impact, though the technology remains unready for full-scale adoption and ongoing concerns about ethics and bias persist.
By Jessica Hagen and Anthony Vecchione | 10:00 am | January 02, 2025
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.
By Jessica Hagen | 09:00 am | December 27, 2024
Some executives anticipate an acceleration of M&A activity as struggling startups seek exits, while others foresee more funding opportunities for companies with proven value in the sector.
By Jessica Hagen and Anthony Vecchione | 03:29 pm | December 23, 2024
Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.
By Jessica Hagen | 01:30 pm | December 19, 2024
Digital health leaders reveal the year's noteworthy events, including the rise in AI valuations, spike in demand for emergency contraception, realizations pertaining to LLMs and more.
By Jessica Hagen | 01:33 pm | December 12, 2024
Industry executives share their thoughts on the year's digital health developments - from an increased focus on women’s health to the rise of generative AI.
By Jessica Hagen | 09:30 am | December 12, 2024
The company will fund and develop companies that focus on eight key areas in healthcare and create AI/genAI technologies that help advance those areas.